USA – FDA: No clear proof NSAIDS can worsen COVID-19

The Food and Drug Administration (FDA) has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).

According to the agency, there is not enough scientific evidence to link the use of NSAIDs to worsening symptoms of COVID-19. Reports about a possible association began after a letter was published in the journal Lancet Respiratory Medicine. The authors hypothesized that since ibuprofen increases an enzyme (angiotensin-converting enzyme 2 [ACE2]) through which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to target cells, its use could potentially “facilitate infection with COVID-19”…